Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Bilgehan SahinBanu AtalarEsra Kaytan SaglamZuleyha AkgunUfuk AbaciogluAlptekin ArifogluEnis OzyarGokhan YaprakNaciye Ozseker IsikYıldız GuneyHale Basak CaglarSule KaramanSefik IgdemUgur SelekTanju BerberFazilet Oner DincbasMeric SengozSerap YucelAyşe Nur DemiralSerap AkyurekPublished in: The clinical respiratory journal (2020)
SABR produced encouraging results, with satisfactory LC and OS and minimal toxicity. BED10 > 120 Gy was needed for better LC and OS for large, non-adenocarcinoma tumors.